China resources medical holdings limited (“CR Medical” for short) is a leading comprehensive medical listed company in the capital markets of the mainland and Hong Kong, it is the only listed platform of CR Healthcare. CR Healthcare is a wholly-owned subsidiary of CR Group. CR Medical has 146 medical institutions, including 13 level-iii hospitals, 27 level-ii hospitals and 32 level-i hospitals. The total number of operating beds is 21,985, covering 10 provinces, regions and municipalities.
By means of“M & a-integration-injection”, CR Medical resources are professionally integrated and capitalized to steadily expand the distribution of medical service network and improve the effect of regional medical resources integration. It acquired 33 high-quality medical institutions in 2022, which increases the number of open beds by 11,130. The company's medical service capacity has been further enhanced and its profit contribution has been significantly enhanced .The company's overall strength continues to grow, and long-term value is steadily rising.
CR Medical makes full use of the advantages of group operation and fine management to create a medical operation mode with CR Characteristics. Taking the construction of regional leading hospitals and regional medical consortia as the carrier, the company constantly improves the subject construction level, patient service quality and intelligence construction ability of its medical institutions through integrated and efficient organization and management. The company provides high-quality and accessible general hospital, Specialized Hospital, health care and innovative business services to meet the growing demand for multi-level and diversified medical and health services.
CR Medical drives high-quality development with ESG concept, improves the management structure, improves the management level, strengthens the information disclosure, and helps construction of the Chinese characteristic medical listed company valuation system. For two consecutive years, the company was selected as“Central enterprise ESG · Pioneer 50 series index”, and the performance case“China Resources Medical Patient Service system construction obvious effect” was selected as“Central enterprise ESG excellent case” in 2022, the 2023 it has been included in the leading ESG Index of central government-owned enterprises on the Hang Seng Hong Kong Stock Connect.
Looking to the future, CR Medical will uphold the“All for public health” mission of the enterprise, actively implement the“Healthy China” strategy, and strive to create a leading domestic medical and health industry group. The company will build and symbiosis of the great health value ecosystem, improve the overall quality of medical care and service level to benefit patients and society.
